[{"AccountsPayableCurrent_0_Q2_USD":2659600.0,"OperatingLeasePayments_2_Q2_USD":430700.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":3139900.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":401000.0,"OperatingLeaseLiability_0_Q2_USD":3540900.0,"OperatingLeaseExpense_2_Q2_USD":446500.0,"OperatingLeaseExpense_1_Q2_USD":210800.0,"OperatingIncomeLoss_2_Q2_USD":-20545700.0,"OperatingIncomeLoss_1_Q2_USD":-12799500.0,"OperatingExpenses_2_Q2_USD":21257800.0,"OperatingExpenses_1_Q2_USD":13157500.0,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":-21275900.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":-13169600.0,"NetIncomeLoss_3_Q2_USD":-20538900.0,"NetIncomeLoss_2_Q2_USD":-20538900.0,"NetIncomeLoss_1_Q2_USD":-12794400.0,"NetCashProvidedByUsedInOperatingActivities_3_Q2_USD":-17622500.0,"NetCashProvidedByUsedInInvestingActivities_3_Q2_USD":-200400.0,"NetCashProvidedByUsedInFinancingActivities_3_Q2_USD":8341700.0,"LiabilitiesNoncurrent_0_Q2_USD":11927800.0,"LiabilitiesCurrent_0_Q2_USD":7912200.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":100499700.0,"Liabilities_0_Q2_USD":19840000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":1009500.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":3029100.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":338000.0,"OperatingLeaseRightOfUseAssetAmortizationExpense_3_Q2_USD":190500.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":0.0,"TreasuryStockValue_0_Q2_USD":3968100.0,"TreasuryStockCommonShares_0_Q2_shares":135665.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":45100.0,"StockholdersEquity_0_Q2_USD":80659700.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_Q2_pure":0.0,"ShareBasedCompensation_3_Q2_USD":1354900.0,"RevenueFromContractWithCustomerIncludingAssessedTax_2_Q2_USD":712100.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q2_USD":358000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-240380600.0,"ResearchAndDevelopmentExpense_2_Q2_USD":15670300.0,"ResearchAndDevelopmentExpense_1_Q2_USD":10066700.0,"RepaymentsOfNotesPayable_3_Q2_USD":0.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":496600.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":1721900.0,"ProceedsFromWarrantExercises_2_Q2_USD":4254800.0,"ProceedsFromNotesPayable_3_Q2_USD":0.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":2676800.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"PreferredStockDividendsIncomeStatementImpact_2_Q2_USD":737000.0,"PreferredStockDividendsIncomeStatementImpact_1_Q2_USD":375200.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q2_USD":200400.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":0.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":62600.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":193227841.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":766000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":812700.0,"CommonStockSharesIssued_0_Q2_shares":196558785.0,"CommonStockSharesAuthorized_0_Q2_shares":325000000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"CommitmentsAndContingencies_0_Q2_USD":null,"ClassOfWarrantOrRightOutstanding_0_Q2_shares":11842104.0,"ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_0_Q2_shares":4814545.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q2_USD":-9481200.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":93627100.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":93627100.0,"CapitalizedContractCostNetNoncurrent_0_Q2_USD":167200.0,"CapitalizedContractCostNetCurrent_0_Q2_USD":133500.0,"CapitalizedContractCostNet_0_Q2_USD":300700.0,"AssetsCurrent_0_Q2_USD":96437400.0,"Assets_0_Q2_USD":100499700.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":31520424.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":1354900.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":764500.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":764500.0,"AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_1_Q2_USD":375200.0,"AdditionalPaidInCapital_0_Q2_USD":324808000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":1225300.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":304800.0,"AccruedLiabilitiesCurrent_0_Q2_USD":3430100.0,"CommonStockValue_0_Q2_USD":196500.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":789000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":1420200.0,"DeferredCosts_0_Q2_USD":167200.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":726000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":4550400.0,"LesseeOperatingLeaseDiscountRate_0_Q2_pure":0.0854,"InterestIncomeExpenseNet_2_Q2_USD":10200.0,"InterestIncomeExpenseNet_1_Q2_USD":5100.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q2_USD":1841700.0,"IncreaseDecreaseInOperatingLeaseLiability_3_Q2_USD":-174700.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3_Q2_USD":3688800.0,"IncomeTaxExpenseBenefit_2_Q2_USD":3400.0,"IncomeTaxExpenseBenefit_1_Q2_USD":0.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-20535500.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-12794400.0,"GeneralAndAdministrativeExpense_2_Q2_USD":5587500.0,"GeneralAndAdministrativeExpense_1_Q2_USD":3090800.0,"FinanceLeasePrincipalPayments_3_Q2_USD":1800.0,"FinanceLeaseLiabilityCurrent_0_Q2_USD":1300.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":1992000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.11,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.07,"DepreciationDepletionAndAmortization_2_Q2_USD":71200.0,"DepreciationDepletionAndAmortization_1_Q2_USD":36700.0,"DepositsAssetsNoncurrent_0_Q2_USD":47800.0,"DeferredCostsCurrent_0_Q2_USD":133500.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":1778200.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":191585026.0,"Ticker":"VTGN","CIK":"1411685","name":"VISTAGEN THERAPEUTICS, INC.","OfficialName":"VistaGen Therapeutics Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2022.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"309791933.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211110"}]